CAG
IHE icon

Csenge Advisory Group’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Csenge Advisory Group’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$277K Hold
3,200
– – 0.01% 594
2025
Q4 		$271K Buy
+3,200
New +$255K 0.01% 599
2018
Q4 		– Sell
-270
Closed -$13K – 780
2018
Q3 		$13K Buy
+270
New +$14.8K 0.01% 459

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

Csenge Advisory Group's IHE Position: Q1 2026 in Review

Csenge Advisory Group held its iShares US Pharmaceuticals ETF (IHE) position steady in Q1 2026 at 3,200 shares worth $277K. The position accounts for 0.01% of the portfolio, ranked #594.

Csenge Advisory Group first reported a position in IHE in Q3 2018 and has held it in 3 quarters since. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • Csenge Advisory Group held 3,200 shares of iShares US Pharmaceuticals ETF worth $277K as of Q1 2026.
  • Csenge Advisory Group left its iShares US Pharmaceuticals ETF share count unchanged in Q1 2026.
  • iShares US Pharmaceuticals ETF made up 0.01% of Csenge Advisory Group's portfolio in Q1 2026, its #594 holding.
  • Csenge Advisory Group first reported a position in iShares US Pharmaceuticals ETF in Q3 2018 and has held it in 3 quarters since.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on Csenge Advisory Group's 13F filing for Q1 2026, filed 30 Apr 2026.